Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$268.59-6.64 (-2.41%)
Delayed quote: Sep 8, 2026, 11:10 AM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 8, 2026, 11:10 AM EDT
Basis: latest reported fiscal quarter. Source: stored company filings; unavailable inputs remain N/A.
The latest quarterly quarterly net income is $5.53B with a quarterly period change of +5.71%. Quarterly net income is profit after expenses, taxes, interest, and other items for the latest fiscal quarter.
Reported quarterly net income; no daily interpolation.
| Period | Quarterly Net Income | % Change |
|---|---|---|
| Quarter ended Jun 2026 | $5.53B | +5.71% |
| Quarter ended Mar 2026 | $5.24B | +2.33% |
| Quarter ended Dec 2025 | $5.12B | (0.70%) |
| Quarter ended Sep 2025 | $5.15B | (6.95%) |
| Quarter ended Jun 2025 | $5.54B | (49.66%) |
| Quarter ended Mar 2025 | $11.00B | +220.58% |
| Quarter ended Dec 2024 | $3.43B | +27.36% |
| Quarter ended Sep 2024 | $2.69B | (42.51%) |
| Quarter ended Jun 2024 | $4.69B | +43.96% |
| Quarter ended Mar 2024 | $3.25B | (19.61%) |
| Quarter ended Dec 2023 | $4.05B | (84.44%) |
| Quarter ended Oct 2023 | $26.03B | +405.99% |
| Quarter ended Jul 2023 | $5.14B | N/A |
| Quarter ended Apr 2023 | ($68.00M) | (101.93%) |
| Quarter ended Dec 2022 | $3.52B | (21.04%) |
| Quarter ended Oct 2022 | $4.46B | (7.40%) |
| Quarter ended Jul 2022 | $4.81B | (6.51%) |
| Quarter ended Apr 2022 | $5.15B | +8.72% |
| Quarter ended Dec 2021 | $4.74B | +29.15% |
| Quarter ended Oct 2021 | $3.67B | (41.59%) |
| Quarter ended Jul 2021 | $6.28B | +1.31% |
| Quarter ended Apr 2021 | $6.20B | +256.56% |
| Quarter ended Dec 2020 | $1.74B | (51.10%) |
| Quarter ended Sep 2020 | $3.55B | (1.99%) |
| Quarter ended Jun 2020 | $3.63B | (37.44%) |
| Quarter ended Mar 2020 | $5.80B | +44.54% |
| Quarter ended Dec 2019 | $4.01B | +128.75% |
| Quarter ended Sep 2019 | $1.75B | (68.74%) |
| Quarter ended Jun 2019 | $5.61B | +49.56% |
| Quarter ended Mar 2019 | $3.75B | +23.24% |
| Quarter ended Dec 2018 | $3.04B | (22.67%) |
| Quarter ended Sep 2018 | $3.93B | (0.51%) |
| Quarter ended Jul 2018 | $3.95B | (9.46%) |
| Quarter ended Apr 2018 | $4.37B | N/A |
| Quarter ended Dec 2017 | ($10.71B) | (384.62%) |
| Quarter ended Oct 2017 | $3.76B | (1.65%) |
| Quarter ended Jul 2017 | $3.83B | (13.46%) |
| Quarter ended Apr 2017 | $4.42B | +15.94% |
| Quarter ended Dec 2016 | $3.81B | (10.72%) |
| Quarter ended Oct 2016 | $4.27B | +6.88% |
| Quarter ended Jul 2016 | $4.00B | (10.32%) |
| Quarter ended Apr 2016 | $4.46B | +38.63% |
| Quarter ended Dec 2015 | $3.21B | (4.26%) |
| Quarter ended Sep 2015 | $3.36B | (25.64%) |
| Quarter ended Jun 2015 | $4.52B | +4.54% |
| Quarter ended Mar 2015 | $4.32B | +71.36% |
| Quarter ended Dec 2014 | $2.52B | (46.92%) |
| Quarter ended Sep 2014 | $4.75B | +9.78% |
| Quarter ended Jun 2014 | $4.33B | (8.48%) |
| Quarter ended Mar 2014 | $4.73B | +34.33% |
| Quarter ended Dec 2013 | $3.52B | +18.01% |
| Quarter ended Sep 2013 | $2.98B | (22.20%) |
| Quarter ended Jun 2013 | $3.83B | +9.61% |
| Quarter ended Mar 2013 | $3.50B | +36.23% |
| Quarter ended Dec 2012 | $2.57B | (13.51%) |
| Quarter ended Sep 2012 | $2.97B | +110.80% |
| Quarter ended Jul 2012 | $1.41B | (63.99%) |
| Quarter ended Apr 2012 | $3.91B | N/A |
| Quarter ended Dec 2011 | $218.00M | (93.19%) |
| Quarter ended Oct 2011 | $3.20B | +15.35% |
| Quarter ended Jul 2011 | $2.78B | (20.14%) |
| Quarter ended Apr 2011 | $3.48B | +78.99% |
| Quarter ended Dec 2010 | $1.94B | (43.17%) |
| Quarter ended Oct 2010 | $3.42B | (0.93%) |
| Quarter ended Jul 2010 | $3.45B | (23.80%) |
| Quarter ended Apr 2010 | $4.53B | +105.17% |
| Quarter ended Dec 2009 | $2.21B | (34.05%) |
| Quarter ended Sep 2009 | $3.35B | +4.27% |
| Quarter ended Jun 2009 | $3.21B | (8.53%) |
| Quarter ended Mar 2009 | $3.51B | +29.22% |
| Quarter ended Dec 2008 | $2.71B | (18.01%) |
| Quarter ended Sep 2008 | $3.31B | (0.51%) |
| Quarter ended Jun 2008 | $3.33B | (7.53%) |
| Quarter ended Mar 2008 | $3.60B | +51.56% |
| Quarter ended Dec 2007 | $2.37B | (6.83%) |
| Quarter ended Sep 2007 | $2.55B | (17.30%) |
| Quarter ended Jul 2007 | $3.08B | +19.74% |
| Quarter ended Apr 2007 | $2.57B | +18.68% |
| Quarter ended Dec 2006 | $2.17B | (21.45%) |
| Quarter ended Oct 2006 | $2.76B | (2.13%) |
| Quarter ended Jul 2006 | $2.82B | (14.67%) |
| Quarter ended Apr 2006 | $3.31B | +51.40% |
| Quarter ended Dec 2005 | $2.18B | (13.99%) |
| Quarter ended Oct 2005 | $2.54B | (1.93%) |
| Quarter ended Jul 2005 | $2.59B | (8.84%) |
| Quarter ended Apr 2005 | $2.84B | +133.28% |
| Quarter ended Dec 2004 | $1.22B | (48.01%) |
| Quarter ended Sep 2004 | $2.34B | (4.76%) |
| Quarter ended Jun 2004 | $2.46B | (1.40%) |
| Quarter ended Mar 2004 | $2.49B | +35.12% |
| Quarter ended Dec 2003 | $1.84B | (10.96%) |
| Quarter ended Sep 2003 | $2.07B | +71.24% |
| Quarter ended Jun 2003 | $1.21B | (41.55%) |
| Quarter ended Mar 2003 | $2.07B | +49.57% |
| Quarter ended Dec 2002 | $1.38B | (19.77%) |
| Quarter ended Sep 2002 | $1.73B | N/A |